WebApr 6, 2024 · Fintel reports that on April 13, 2024, Canaccord Genuity maintained coverage of Apple (NASDAQ:AAPL) with a Buy recommendation. Analyst Price Forecast Suggests 8.49% Upside As of April 6, 2024,... Web16 hours ago · REDWOOD CITY, Calif., April 13, 2024 /PRNewswire/ -- Arcellx Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the …
Investor Relations - Canaccord Genuity
Web2 days ago · Through its principal subsidiaries, Canaccord Genuity Group Inc. (the "Company") is a leading independent, full-service financial services firm, with operations … WebJan 31, 2024 · 16:40 06/04/23. 1.86%. 2.40p. Canaccord Genuity said the asset managers' peer group had "re-rated meaningfully" since the beginning of the fourth quarter of 2024, helped by higher market levels ... diamond tennis bracelet princess cut
Sensei Biotherapeutics to Participate in Canaccord Genuity
WebFeb 4, 2024 · News provided by. Canaccord Genuity Group Inc. Feb 03, 2024, 20:10 ET. Share this article. Share this article. Proceeds to be used to fund a return of capital from the UK Wealth Management ... WebApr 5, 2024 · Apr. 5, 2024, 06:35 AM. In a report released today, Joseph Vafi from Canaccord Genuity reiterated a Buy rating on Nuvei Corp ( NVEI – Research Report ), with a price target of $70.00. The ... WebApr 6, 2024 · According to analysts' consensus price target of $11.50, Canaccord Genuity Group has a forecasted upside of 44.3% from its current price of $7.97. Amount of Analyst Coverage Canaccord Genuity Group has only been the subject of 1 research reports in the past 90 days. See Top Rated MarketRank™ Stocks Here Sponsored Advertiser Disclosure cis homes ltd gloucester